Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use.

Humans Adult Cannabis / adverse effects Marijuana Abuse / diagnosis Diagnostic and Statistical Manual of Mental Disorders Reproducibility of Results Substance-Related Disorders / epidemiology Hallucinogens
Cannabis use disorder Differential functioning Dimensionality Item response theory Psychometrics

Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
07 2023
Historique:
received: 05 12 2022
revised: 02 05 2023
accepted: 15 05 2023
pmc-release: 01 07 2024
medline: 12 6 2023
pubmed: 25 5 2023
entrez: 24 5 2023
Statut: ppublish

Résumé

The DSM-5 criteria for cannabis use disorder (CUD) combine DSM-IV dependence and abuse criteria (without legal problems) and new withdrawal and craving criteria. Information on dimensionality, internal reliability, and differential functioning of the DSM-5 CUD criteria is lacking. Additionally, dimensionality of the DSM-5 withdrawal items is unknown. This study examined the psychometric properties of the DSM-5 CUD criteria among adults who used cannabis in the past 7 days (N = 5,119). Adults with frequent cannabis use were recruited from the US general population through social media and filled in a web-based survey about demographics and cannabis use behaviors. Factor analysis was used to assess dimensionality, and item response theory analysis models were used to explore relationships between the criteria and the underlying latent trait (CUD), and whether each criterion and the criteria set functioned differently by demographic and clinical characteristics: sex, age, state-level cannabis laws, reasons for cannabis use, and frequency of use. The DSM-5 CUD criteria showed unidimensionality and provided information about the CUD latent trait across the severity spectrum. The cannabis withdrawal items indicated one underlying latent factor. While some CUD criteria functioned differently in specific subgroups, the criteria set as a whole functioned similarly across subgroups. In this online sample of adults with frequent cannabis use, evidence supports the reliability, validity, and utility of the DSM-5 CUD diagnostic criteria set, which can be used for determining a major risk of cannabis use, i.e., CUD, to inform cannabis policies and public health messaging, and for developing intervention strategies.

Identifiants

DOI: 10.1016/j.jpsychires.2023.05.048 PMID: 37224773 PMC: PMC10330577
pubmed: 37224773
pii: S0022-3956(23)00236-4
doi: 10.1016/j.jpsychires.2023.05.048
pmc: PMC10330577
mid: NIHMS1904197
pii:
doi:

Substances chimiques

Hallucinogens 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-221

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA048860
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA050032
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA031099
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA037202
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Alan Budney has served as a scientific consultant for Canopy Growth, Inc. and Jazz Pharmaceuticals. All other authors have no conflicts of interest to declare.

Références

Int J Methods Psychiatr Res. 2012 Jun;21(2):117-33
pubmed: 22351489
Psychol Med. 2007 Sep;37(9):1345-55
pubmed: 17407621
Addiction. 2011 Sep;106(9):1675-86
pubmed: 21545668
J Abnorm Psychol. 2004 Feb;113(1):72-80
pubmed: 14992659
Appl Psychol Meas. 2020 Mar;44(2):118-136
pubmed: 32076356
Psychol Addict Behav. 2012 Mar;26(1):68-77
pubmed: 22082343
Am J Psychiatry. 2013 Aug;170(8):834-51
pubmed: 23903334
Addict Behav. 2023 May;140:107617
pubmed: 36736229
Drug Alcohol Depend. 2009 Mar 1;100(3):221-7
pubmed: 19062204
Psychol Med. 2019 Apr;49(6):931-939
pubmed: 29947307
Ann Intern Med. 2018 Jul 17;169(2):106-115
pubmed: 29971337
Lancet Psychiatry. 2016 Oct;3(10):954-964
pubmed: 27592339
Drug Alcohol Depend. 2015 Mar 1;148:40-6
pubmed: 25604321
Neuropsychopharmacology. 2018 Jan;43(1):34-51
pubmed: 28811670
J Stud Alcohol Drugs. 2013 Mar;74(2):320-8
pubmed: 23384380
Neuropharmacology. 2021 Aug 1;193:108610
pubmed: 34010617
Drug Alcohol Depend. 2015 Mar 1;148:27-33
pubmed: 25595052
Am J Addict. 2006 Jan-Feb;15(1):8-14
pubmed: 16449088
J Med Internet Res. 2018 Jun 18;20(6):e197
pubmed: 29914861
Drug Alcohol Depend. 2012 Apr 1;122(1-2):28-37
pubmed: 21963333
Subst Use Misuse. 2022;57(7):1052-1061
pubmed: 35435131
Ann N Y Acad Sci. 2012 Feb;1248:1-17
pubmed: 22172057
Addict Behav. 2021 May;116:106797
pubmed: 33450665
Addiction. 2011 Jun;106(6):1137-45
pubmed: 21205060
Internet Interv. 2016 Jan 06;4:1-10
pubmed: 30135786
Addiction. 1999 Jun;94(6):843-55
pubmed: 10665074
Am J Psychiatry. 2022 Oct;179(10):748-757
pubmed: 35899381
Drug Alcohol Depend. 2012 Jun 1;123(1-3):141-7
pubmed: 22153944
J Clin Psychiatry. 2008 Sep;69(9):1354-63
pubmed: 19012815
Drug Alcohol Depend. 2014 Jan 1;134:362-369
pubmed: 24315570
Annu Rev Clin Psychol. 2016;12:407-33
pubmed: 26565121
Cannabis Cannabinoid Res. 2022 Dec 26;:
pubmed: 36577020
J Am Geriatr Soc. 2021 Sep;69(9):2591-2597
pubmed: 34037250
Eur Neuropsychopharmacol. 2020 Apr;33:1-35
pubmed: 32165103
J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):165-173
pubmed: 18176333
J Abnorm Psychol. 2006 Nov;115(4):807-14
pubmed: 17100538
SAGE Open Med. 2021 Mar 9;9:20503121211000909
pubmed: 33786179
Neuropsychopharmacology. 2018 Jan;43(1):195-212
pubmed: 28853439
Am J Psychiatry. 2004 Nov;161(11):1967-77
pubmed: 15514394
Drug Alcohol Depend. 2019 Feb 1;195:170-177
pubmed: 30361043
Addiction. 2010 Jul;105(7):1246-53
pubmed: 20491729
Med Care. 2006 Nov;44(11 Suppl 3):S143-51
pubmed: 17060821
Subst Abus. 2022;43(1):408-414
pubmed: 34214395
JAMA Psychiatry. 2017 Jun 1;74(6):559-560
pubmed: 28445570
Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109159
pubmed: 34844095
Addict Behav. 2010 May;35(5):408-13
pubmed: 20071097
Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109137
pubmed: 34763137
Internet Interv. 2016 Apr 27;4:72-81
pubmed: 30135792
Drug Alcohol Depend. 2020 Jul 1;212:108036
pubmed: 32464467
Addict Behav. 2020 Oct;109:106479
pubmed: 32485547
Drug Alcohol Depend Rep. 2022 Dec;5:
pubmed: 36741544
Multivariate Behav Res. 2009 Jan-Feb;44(1):1-27
pubmed: 26795105
Addict Behav. 2022 Oct;133:107374
pubmed: 35644057
Am J Psychiatry. 2016 Jun 1;173(6):588-99
pubmed: 26940807
Addiction. 2007 Jun;102(6):920-30
pubmed: 17523987
Cannabis Cannabinoid Res. 2022 Dec 15;:
pubmed: 36521175
JAMA Psychiatry. 2015 Dec;72(12):1235-42
pubmed: 26502112
Drug Alcohol Depend. 2019 Nov 1;204:107468
pubmed: 31586809

Auteurs

Dvora Shmulewitz (D)

Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA; New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA. Electronic address: ds1019@cumc.columbia.edu.

Alan J Budney (AJ)

Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine, 46 Centerra Pkwy, Lebanon, NH, 03766, USA; Department of Biomedical Data Science, Dartmouth Geisel School of Medicine, 1 Rope Ferry Road, Hanover, NH, 03755, USA. Electronic address: alan.budney@dartmouth.edu.

Jacob T Borodovsky (JT)

Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine, 46 Centerra Pkwy, Lebanon, NH, 03766, USA; Department of Biomedical Data Science, Dartmouth Geisel School of Medicine, 1 Rope Ferry Road, Hanover, NH, 03755, USA. Electronic address: jacob.t.borodovsky@dartmouth.edu.

Julia M Bujno (JM)

New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA. Electronic address: julia.bujno@nyspi.columbia.edu.

Claire A Walsh (CA)

New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA. Electronic address: claire.walsh@nyspi.columbia.edu.

Cara A Struble (CA)

Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine, 46 Centerra Pkwy, Lebanon, NH, 03766, USA; Department of Biomedical Data Science, Dartmouth Geisel School of Medicine, 1 Rope Ferry Road, Hanover, NH, 03755, USA. Electronic address: cara.a.struble@dartmouth.edu.

Ofir Livne (O)

New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA; Department of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY, 10032, USA. Electronic address: ol2166@cumc.columbia.edu.

Mohammad I Habib (MI)

Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine, 46 Centerra Pkwy, Lebanon, NH, 03766, USA. Electronic address: mohammad.i.habib@dartmouth.edu.

Efrat Aharonovich (E)

New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA. Electronic address: efrat.aharonovich@nyspi.columbia.edu.

Deborah S Hasin (DS)

Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA; New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA; Department of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY, 10032, USA. Electronic address: deborah.hasin@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Dimensionality and differential functioning of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Dimensionality and differential functioning of...
questionsmedicales.fr › Eucaryotes › Viridiplantae › Streptophyta › Embryophyta › Tracheobionta › Magnoliopsida › Rosanae › Rosales › Cannabaceae › Cannabis › Dimensionality and differential functioning of...
questionsmedicales.fr › Troubles mentaux › Troubles liés à une substance › Abus de marijuana › Dimensionality and differential functioning of...
questionsmedicales.fr › Sciences de l'information › Sources d'information › Services d'information › Documentation › Vocabulaire contrôlé › Diagnostic and stastistical manual of mental disorders (USA) › Dimensionality and differential functioning of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Dimensionality and differential functioning of...
questionsmedicales.fr › Troubles mentaux › Troubles liés à une substance › Dimensionality and differential functioning of...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Psychoanaleptiques › Hallucinogènes › Dimensionality and differential functioning of...